Abstract
Aim:
To examine the tolerance of type 1 diabetic hearts to ischemia and reperfusion injury. Myocardial contents of 27-kDa and 70-kDa heat shock proteins (hsp) as well as phosphorylated hsp27 were also determined.
Methods:
Hearts from hyperglycemic rats 3 weeks after streptozocin injection and age-matched normal rats were subjected to ischemia and reperfusion in vitro. Cardiac function and electrocardiogram were recorded throughout experiments. Myocardial heat shock proteins were detected with Western blot.
Results:
Despite depressed systolic function at the baseline, diabetic hearts exhibited considerable enhancement in postischemic heart function, manifested by an increase in the maximal rate of left ventricular pressure rise and fall (post-ischemic dp/dtmax and dp/dtmin were 560±117 and -313±68 mmHg/s in control, n=7, 1249±57 and -1204±36 mmHg/s in diabetes, n=10, P < 0.01). Reperfusion ventricular fibrillation in the diabetic group were attenuated compared with controls (1.5±0.3 vs 7.2±2.1 min in control, P < 0.01). The increased heart resistance to ischemia in diabetes was associated with hyperglycemia and accompanied by enhanced expression of myocardial phosphorylated hsp27 with normal aortic vessel relaxation. Cardioprotection was abrogated by metabolic correction with insulin and accompanied by phospho-hsp27 reduction.
Conclusion:
Heart resistance to ischemia is increased in type 1 diabetes, and hyperglycemia may present a mild yet stressful stimulus leading to upregulation of endogenous stress protein, which may play a potential role in cardioprotection and compensate for detrimental effects of hyperglycemia in diabetes.
Similar content being viewed by others
Article PDF
References
Buse JB . Should postprandial glucose be routinely measured and treated to a particular target? No! Diabetes Care 2003; 26: 1615–8.
Balkau B, Forhan A, Eschwege E . Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study. Diabetologia 2002; 45: 1224–30.
Jarrett RJ . Type 2 (non-insulin-dependent) diabetes mellitus and coronary heart disease – chicken, egg or neither? Diabetologia 1984; 26: 99–102.
Meigs JB, Singer DE, Sullivan LM, Dukes KA, D'Agostino RB, Nathan DM, et al. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med 1997; 102: 38–47.
Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW . Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 1993; 88: 1273–8.
Marfella R, D'Amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, et al. Myocardial infarction in diabetic rats: role of hyperglycaemia on infarct size and early expression of hypoxia-inducible factor 1. Diabetologia 2002; 45: 1172–81.
Feuvray D, Lopaschuk GD . Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovasc Res 1997; 34: 113–20.
Ramasamy R, Schaefer S . Inhibition of Na+-H+ exchanger protects diabetic and non-diabetic hearts from ischemic injury: insight into altered susceptibility of diabetic hearts to ischemic injury. J Mol Cell Cardiol 1999; 31: 785–97.
Tani M, Neely JR . Hearts from diabetic rats are more resistant to in vitro ischemia: possible role of altered Ca2+ metabolism. Circ Res 1988; 62: 931–40.
Aasum E, Hafstad AD, Severson DL, Larsen TS . Age-dependent changes in metabolism, contractile function, and ischemic sensitivity in hearts from db/db mice. Diabetes 2003; 52: 434–41.
Stern MP . Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 1995; 44: 369–74.
Sowers JR, Epstein M, Frohlich ED . Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053–9.
Weitgasser R, Lechleitner M, Koch T, Galvan G, Muhlmann J, Steiner K, et al. Antibodies to heat shock protein 65 and neopterin levels in patients with type 1 diabetes mellitus. Exp Clin Endocrinol Diabetes 2003; 111: 127–31.
Curtis MJ, Walker MJ . Quantification of arrhythmia using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 1988; 22: 656–65.
Ravingerova T, Neckar J, Kolar F, Stetka R, Volkovova K, Ziegelhoffer A, et al. Ventricular arrhythmias following coronary artery occlusion in rats: is the diabetic heart less or more sensitive to ischaemia? Basic Res Cardiol 2001; 96: 160–8.
Ramasamy R, Oates PJ, Schaefer S . Aldose reductase inhibition protects diabetic and nondiabetic rat hearts from ischemic injury. Diabetes 1997; 46: 292–300.
Chen H, Higashino H, Kamenov ZA, Azuma M, Lee WH, Yang XQ, et al. Preserved postischemic heart function in sucrose-fed type 2 diabetic OLETF rats. Life Sci 2003; 72: 2839–51.
Latchman DS . Heat shock proteins and cardiac protection. Cardiovasc Res 2001; 51: 637–46.
Dana A, Skarli M, Papakrivopoulou J, Yellon DM . Adenosine A1 receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. Circ Res 2000; 86: 989–97.
Wang LP, Liu T, Chen H, Chen HZ, Gao PJ, Zhu DL . Experimental study on paradoxical phenomenon in type 1 diabetic heart: increased resistance to ischemia/reperfusion injury. Shanghai Med J 2004; 91: 300–6.
Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS . Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. Am J Physiol 1995; 269: H1767–H1775.
Chen H, Higashino H, Maeda K, Zhang Z, Ohta Y, Wang Z, et al. Reduction of cardiac norepinephrine improves postischemic heart function in stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2001; 38: 821–32.
Shen B, Ye CL, Ye KH, Liu JJ, Sun P, Jiang JH . Mechanism underlying enhanced endothelium-dependent vasodilation in thoracic aorta of early stage streptozotocin-induced diabetic mice. Acta Pharmacol Sin 2003; 24: 422–8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by Major State Basic Research Development Program of China (Grant No G2000056905).
Rights and permissions
About this article
Cite this article
Chen, H., Wu, Xj., Lu, Xy. et al. Phosphorylated heat shock protein 27 is involved in enhanced heart tolerance to ischemia in short-term type 1 diabetic rats. Acta Pharmacol Sin 26, 806–812 (2005). https://doi.org/10.1111/j.1745-7254.2005.00113.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2005.00113.x
Keywords
This article is cited by
-
Small Heat Shock Proteins HSP10 and HSP27 in the Left Ventricular Myocardium in Rats with Arterial Hypertension and Insulin-Dependent Diabetes Mellitus
Bulletin of Experimental Biology and Medicine (2021)
-
Change in post‐translational modifications of histone H3, heat‐shock protein‐27 and MAP kinase p38 expression by curcumin in streptozotocin‐induced type I diabetic nephropathy
British Journal of Pharmacology (2008)
-
Protection of the abnormal heart
Heart Failure Reviews (2007)
-
Enhanced tolerance of the rat myocardium to ischemia and reperfusion injury early after acute myocardial infarction
Basic Research in Cardiology (2007)